These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 6868009)

  • 1. Antithrombin III infusion in patients undergoing peritoneovenous shunt operation: failure in the prevention of disseminated intravascular coagulation.
    Büller HR; ten Cate JW
    Thromb Haemost; 1983 Apr; 49(2):128-31. PubMed ID: 6868009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bleeding complications of the LeVeen shunt].
    Friedrichs O
    Med Welt; 1983 Jul; 34(27):754-5. PubMed ID: 6888245
    [No Abstract]   [Full Text] [Related]  

  • 3. [Consumption coagulopathies following peritoneojugular bypass. Prevention by a heparin-antithrombin III combination].
    Peyrin JC; Waldmann V; Girardet P; Pouzol P; Duret J; Fargnoli JM; Magne JL; Perron Y
    J Chir (Paris); 1986; 123(6-7):417-23. PubMed ID: 3771670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Five cases of disseminated intravascular coagulation after peritoneojugular shunt by Le Veen valve].
    Jobard J; Marcillon M; Guillot F; Maestracci P
    Ann Anesthesiol Fr; 1980; 21(5):531-4. PubMed ID: 6109502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneovenous shunting for cirrhotic versus malignant ascites.
    Kostroff KM; Ross DW; Davis JM
    Surg Gynecol Obstet; 1985 Sep; 161(3):204-8. PubMed ID: 2412302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disseminated intravascular coagulation caused by re-infusion of ascitic fluid. Correlations between pro-aggregant and pro-coagulant factors of the ascitic fluid].
    Armani U; Testa R; Piana A; Dellepiane F; Bonadonna R
    Arch Maragliano Patol Clin; 1979; 35():53-5. PubMed ID: 263696
    [No Abstract]   [Full Text] [Related]  

  • 7. Complications of peritoneovenous shunt for malignant ascites.
    Lokich J; Reinhold R; Silverman M; Tullis J
    Cancer Treat Rep; 1980; 64(2-3):305-9. PubMed ID: 6157465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical treatment of refractory ascites with peritoneovenous shunt and its complications].
    Brescia A; La Torre F; Pieralisi G
    Ann Ital Chir; 1983; 55(4):385-93. PubMed ID: 6673622
    [No Abstract]   [Full Text] [Related]  

  • 9. Peritoneovenous shunting for intractable ascites.
    Gullstrand P; Alwmark A; Börjesson B; Joelsson B; Bengmark S
    Scand J Gastroenterol; 1982 Nov; 17(8):1009-12. PubMed ID: 7167735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptococcus pneumoniae meningitis in two patients with peritoneovenous shunts.
    Camara DS; Beam TR; Perakos PG; Caruana JA
    Am J Gastroenterol; 1984 Apr; 79(4):287-90. PubMed ID: 6711531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated intravascular coagulation following peritoneo-venous (LeVeen) shunt.
    Gibson PR; Dudley FJ; Jakobovits AW; Salem HH; McInnes IE
    Aust N Z J Med; 1981 Feb; 11(1):8-12. PubMed ID: 6941784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [LeVeen's peritoneojugular shunt for the treatment of ascites].
    Ouwendijk RJ; Schalm SW; Bauer AG; de Groot GH; Terpstra OT; van Urk H
    Ned Tijdschr Geneeskd; 1982 May; 126(21):940-4. PubMed ID: 7099287
    [No Abstract]   [Full Text] [Related]  

  • 13. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
    Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
    Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascites-induced LeVeen shunt coagulopathy.
    Ragni MV; Lewis JH; Spero JA
    Ann Surg; 1983 Jul; 198(1):91-5. PubMed ID: 6859998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
    Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
    Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-infective complications of peritoneovenous anastomosis (LeVeen shunt)].
    Castells LL; Comas P; Lucea D; Charco R; González A; Vargas V
    Rev Esp Enferm Dig; 1992 Nov; 82(5):368-9. PubMed ID: 1485993
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin III concentrate.
    Jespersen J; Rasmussen NR; Sidelmann J
    Acta Chir Scand Suppl; 1982; 509():105-7. PubMed ID: 6962611
    [No Abstract]   [Full Text] [Related]  

  • 18. Coagulopathy of peritoneovenous shunts: studies on the pathogenic role of ascitic fluid collagen and value of antiplatelet therapy.
    Salem HH; Dudley FJ; Merrett A; Perkin J; Firkin BG
    Gut; 1983 May; 24(5):412-7. PubMed ID: 6840615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal pulmonary tumor embolization following peritoneovenous shunting for malignant ascites.
    Smith RR; Sternberg SS; Paglia MA; Golbey RB
    J Surg Oncol; 1981; 16(1):27-35. PubMed ID: 6257978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneovenous shunting for intractable ascites.
    Tyden G; Samnegård H; Thulin L
    Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.